LienTeh.net > Ads > Beigani (Brigatinib)

Beigani (Brigatinib)

Inquire / Price

Model Number：

RL142023090183238
Brand Name：

Beigani
Origin：

Generic drug，Laos
Small Orders：

Small batches also available
Tags：

Lung Cancer

Inquire Now Link

Poster

Details
Description

Packaging Size

21T/Bottle
Strength

30mg&90mg
Compositon

Brigatinib
Treatment

ALK+ non-small cell lung cancer (NSCLC)
Form

Tablet
Brand

Beigani
Quantity Unit

30mg&90mg*21T/bottle
Manufacturer

Tongmeng (Lao) Pharmaceutical & Food Co., Ltd.（TLPH）

Contents hide

1 Non-Small Cell Lung Cancer

2 Dosage Modifications

2.1 Dose reductions

2.1.1 90 mg/day dose

2.1.2 180 mg/day dose

Brigatinib is a targeted cancer drug treatment for non small cell lung cancer (NSCLC). It is also known as Alunbrig. It is a treatment for a type of lung cancer called non small cell lung cancer (NSCLC) that has spread to other parts of the body (advanced or metastatic NSCLC).

Non-Small Cell Lung Cancer

Indicated for anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)

90 mg PO qDay for the first 7 days; if 90 mg/day tolerated, increase to 180 mg PO qDay

Continue until disease progression or unacceptable toxicity

Dosage Modifications

If treatment is interrupted for ≥14 days for reasons other than adverse reactions, resume at 90 mg qDay for 7 days before increasing to previously tolerated dose

Dose reductions

Once discontinued, do not subsequently increase dose

Permanently discontinue if unable to tolerate 60 mg/day

90 mg/day dose
- First reduction: 60 mg qDay
180 mg/day dose
- First reduction: 120 mg qDay
- Second reduction: 90 mg qDay
- Third reduction: 60 mg qDay